• Privatisation tweet

    A probe into a tweet by Tesla chairperson and CEO Elon Musk may open pandora's box.

  • State Capture Inquiry

    Nedbank says ex-Mining Minister Mosebenzi Zwane sought to keep Gupta accounts open.

  • Tighter rules

    'Corporate scandals, rumours and innuendo' has prompted the JSE to plan new listing rules.

Loading...

Sygnia to list on A2X

Sep 06 2018 12:35

Sygnia [JSE:SYG] will next week list on A2X Markets, joining a small clutch of companies already trading their shares on the secondary platform.

The asset management and stockbroking company said in a statement it would begin trading on the alternative board on September 13, but will not issue new share for the listing.

The company will retain its primary listing on the JSE.

"The listing offers Sygnia an opportunity to broaden and diversify its offering to benefit its clients and spur local innovation," said Sygnia CEO, Magda Wierzycka.

"We support disruption, competition and best practice in South Africa’s capital markets. International experience has shown how competition helps drive a more efficient and responsive industry, which ultimately benefits the end consumer and assists in the overall growth of the market," added Wierzycka.

According to the company, there is no cost, risk, or additional regulatory compliance as a result of the secondary listing.

"Making Sygnia’s shares available on a second trading platform gives our shareholders and stockbrokers an additional venue to transact our shares at a lower cost. We see this as complementary to our primary listing," said Wierzycka.

A2X has been operating since October 2017, and had companies like Sanlam, Ascendis Health, and Growthpoint on its board.

* Sign up to Fin24's top news in your inbox: SUBSCRIBE TO FIN24 NEWSLETTER

Follow Fin24 on Twitter and Facebook. 24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

sygnia  |  a2x  |  magda wierzycka  |  shares  |  listing
NEXT ON FIN24X

 
 
 
 

Company Snapshot

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

Did you find Markus Jooste's testimony convincing?

Previous results · Suggest a vote

Loading...